vs

Side-by-side financial comparison of CBL & ASSOCIATES PROPERTIES INC (CBL) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $156.4M, roughly 1.3× CBL & ASSOCIATES PROPERTIES INC). CBL & ASSOCIATES PROPERTIES INC runs the higher net margin — 31.3% vs 6.7%, a 24.6% gap on every dollar of revenue. On growth, CBL & ASSOCIATES PROPERTIES INC posted the faster year-over-year revenue change (18.8% vs 13.6%). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 10.1%).

CBL & Associates Properties, Inc. is an American real estate investment trust that invests in shopping centers and shopping malls, primarily in the Southeastern and Midwestern United States. The company is organized in Delaware with its headquarters in Chattanooga, Tennessee. Its largest market is Chattanooga, Tennessee. The company's name is based on the initials of its founder, Charles B. Lebovitz.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

CBL vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.3× larger
RGEN
$197.9M
$156.4M
CBL
Growing faster (revenue YoY)
CBL
CBL
+5.1% gap
CBL
18.8%
13.6%
RGEN
Higher net margin
CBL
CBL
24.6% more per $
CBL
31.3%
6.7%
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
10.1%
CBL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBL
CBL
RGEN
RGEN
Revenue
$156.4M
$197.9M
Net Profit
$49.0M
$13.3M
Gross Margin
52.5%
Operating Margin
9.0%
Net Margin
31.3%
6.7%
Revenue YoY
18.8%
13.6%
Net Profit YoY
29.0%
143.9%
EPS (diluted)
$1.61
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBL
CBL
RGEN
RGEN
Q4 25
$156.4M
$197.9M
Q3 25
$139.3M
$188.8M
Q2 25
$140.9M
$182.4M
Q1 25
$141.8M
$169.2M
Q4 24
$131.7M
$174.1M
Q3 24
$125.1M
$154.9M
Q2 24
$129.7M
$154.1M
Q1 24
$129.1M
$151.3M
Net Profit
CBL
CBL
RGEN
RGEN
Q4 25
$49.0M
$13.3M
Q3 25
$75.4M
$14.9M
Q2 25
$2.8M
$14.9M
Q1 25
$8.8M
$5.8M
Q4 24
$38.0M
$-30.3M
Q3 24
$16.2M
$-654.0K
Q2 24
$4.7M
$3.3M
Q1 24
$50.0K
$2.1M
Gross Margin
CBL
CBL
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
CBL
CBL
RGEN
RGEN
Q4 25
9.0%
Q3 25
8.9%
Q2 25
7.6%
Q1 25
3.9%
Q4 24
-17.7%
Q3 24
-5.1%
Q2 24
1.0%
Q1 24
1.3%
Net Margin
CBL
CBL
RGEN
RGEN
Q4 25
31.3%
6.7%
Q3 25
54.2%
7.9%
Q2 25
2.0%
8.2%
Q1 25
6.2%
3.4%
Q4 24
28.8%
-17.4%
Q3 24
12.9%
-0.4%
Q2 24
3.7%
2.2%
Q1 24
0.0%
1.4%
EPS (diluted)
CBL
CBL
RGEN
RGEN
Q4 25
$1.61
$0.24
Q3 25
$2.38
$0.26
Q2 25
$0.08
$0.26
Q1 25
$0.27
$0.10
Q4 24
$1.22
$-0.55
Q3 24
$0.52
$-0.01
Q2 24
$0.14
$0.06
Q1 24
$-0.01
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBL
CBL
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$42.3M
$767.6M
Total DebtLower is stronger
$2.2B
$542.2M
Stockholders' EquityBook value
$374.9M
$2.1B
Total Assets
$2.7B
$2.9B
Debt / EquityLower = less leverage
5.79×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBL
CBL
RGEN
RGEN
Q4 25
$42.3M
$767.6M
Q3 25
$52.6M
$748.7M
Q2 25
$100.3M
$708.9M
Q1 25
$100.3M
$697.2M
Q4 24
$40.8M
$757.4M
Q3 24
$65.1M
$784.0M
Q2 24
$57.7M
$809.1M
Q1 24
$57.7M
$780.6M
Total Debt
CBL
CBL
RGEN
RGEN
Q4 25
$2.2B
$542.2M
Q3 25
$2.2B
$537.9M
Q2 25
$2.1B
Q1 25
$2.2B
Q4 24
$2.2B
$525.6M
Q3 24
$1.8B
Q2 24
$1.9B
Q1 24
$1.9B
Stockholders' Equity
CBL
CBL
RGEN
RGEN
Q4 25
$374.9M
$2.1B
Q3 25
$351.4M
$2.1B
Q2 25
$289.4M
$2.1B
Q1 25
$295.0M
$2.0B
Q4 24
$323.5M
$2.0B
Q3 24
$308.3M
$2.0B
Q2 24
$308.8M
$2.0B
Q1 24
$324.2M
$2.0B
Total Assets
CBL
CBL
RGEN
RGEN
Q4 25
$2.7B
$2.9B
Q3 25
$2.7B
$2.9B
Q2 25
$2.6B
$2.9B
Q1 25
$2.6B
$2.9B
Q4 24
$2.7B
$2.8B
Q3 24
$2.2B
$2.8B
Q2 24
$2.3B
$2.9B
Q1 24
$2.3B
$2.8B
Debt / Equity
CBL
CBL
RGEN
RGEN
Q4 25
5.79×
0.26×
Q3 25
6.21×
0.26×
Q2 25
7.39×
Q1 25
7.29×
Q4 24
6.84×
0.27×
Q3 24
5.76×
Q2 24
6.00×
Q1 24
5.74×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBL
CBL
RGEN
RGEN
Operating Cash FlowLast quarter
$249.7M
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
5.10×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBL
CBL
RGEN
RGEN
Q4 25
$249.7M
$25.7M
Q3 25
$69.6M
$48.1M
Q2 25
$68.3M
$28.6M
Q1 25
$31.7M
$15.0M
Q4 24
$202.2M
$39.2M
Q3 24
$61.1M
$49.3M
Q2 24
$64.2M
$42.2M
Q1 24
$30.7M
$44.7M
Free Cash Flow
CBL
CBL
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$46.0M
$42.3M
Q2 24
$54.8M
$37.4M
Q1 24
$24.7M
$36.4M
FCF Margin
CBL
CBL
RGEN
RGEN
Q4 25
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
36.8%
27.3%
Q2 24
42.2%
24.3%
Q1 24
19.1%
24.0%
Capex Intensity
CBL
CBL
RGEN
RGEN
Q4 25
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
12.1%
4.5%
Q2 24
7.3%
3.1%
Q1 24
4.7%
5.5%
Cash Conversion
CBL
CBL
RGEN
RGEN
Q4 25
5.10×
1.93×
Q3 25
0.92×
3.23×
Q2 25
24.74×
1.92×
Q1 25
3.60×
2.57×
Q4 24
5.32×
Q3 24
3.77×
Q2 24
13.54×
12.70×
Q1 24
614.76×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons